WNT5A: a motility-promoting factor in Hodgkin lymphoma

Area of Science:

• Oncology
• Cell Biology
• Molecular Biology

Background:

• Classical Hodgkin lymphoma (cHL) exhibits characteristic lymph node dissemination, but the underlying cell spread mechanisms remain unclear.
• Understanding lymphoma cell migration is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the role of WNT signaling in classical Hodgkin lymphoma cell migration and dissemination.
• To elucidate the specific WNT ligands and downstream pathways involved in cHL cell motility.

Main Methods:

• Comparative analysis of migration rates between cHL and non-Hodgkin lymphoma cell lines.
• Inhibition of WNT secretion using porcupine inhibitors (Wnt-C59/IWP-2).
• WNT5A stimulation, gene knockdown (Frizzled5, Dishevelled3), and pharmacological inhibition (ROCK inhibitor Y-27632/H1152P).
• In vitro time-lapse studies and in vivo chick chorionallantoic membrane (CAM) assay.

Main Results:

• cHL cell lines demonstrate significantly higher migration rates than non-Hodgkin lymphoma lines.
• Autocrine WNT signaling, particularly WNT5A, is essential for cHL cell migration, invasion, and adhesion.
• WNT5A modulates amoeboid cell migration via the Frizzled5/Dishevelled3/RHOA pathway.
• Increased WNT5A expression is observed in primary HL cells compared to normal B-cells and other lymphomas.
• Inhibition of WNT secretion reduced cHL tumor development and associated bleeding in the CAM assay.

Conclusions:

• WNT5A signaling is a key regulator of classical Hodgkin lymphoma cell migration and invasion.
• Targeting WNT secretion or WNT5A pathways presents a potential therapeutic strategy for cHL.
• WNT signaling contributes to tumor-promoting processes in classical Hodgkin lymphoma.